2026 MIDD Webinar Series | Beyond the Simulation: Embedding MIDD into Strategic Drug Development
Includes a Live Web Event on 06/24/2026 at 12:00 PM (EDT)
-
Register
- Non-member - $50
- Member - Free!
This talk explores how model-informed drug development (MIDD) can evolve from a supportive tool into a central pillar of clinical strategy. Using the development of AZD8233—a novel PCSK9 antisense oligonucleotide—as a case study, the presentation will walk through how modeling guided key decisions from Phase 2b to Phase 3, including trial design, dose optimization, and cardiovascular risk prediction.
The MIDD Webinar Series, coordinated by Yash Kapoor and Fulya Akpinar Singh, is a series of webinars focused on shaping the future of drug development and regulatory decision-making sponsored by the ISoP Education Committee. Topics range from MIDD approaches in regulatory submission to pharmacometrics topics that are at the core of model development.
Jane Knöchel
Dr Jane Knöchel is a Tenure-track Assistant Professor at the University of Copenhagen, where she is building a research group at the intersection of mechanistic and data-driven modelling. Her work focuses on methodological advances in pharmacometrics, including synthetic data generation, systems pharmacology modelling, and AI-enhanced analysis. Trained as an applied mathematician, she recently transitioned back to academia after seven years in industry, where she worked in applied pharmacometrics across both large pharmaceutical companies and CROs.
Key:
Complete
Next
Failed
Available
Locked